Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure-activity relationships.
Open Access
- 1 October 1994
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 102 (suppl 6) , 61-67
- https://doi.org/10.1289/ehp.94102s661
Abstract
N-Oxidation and nitroreduction to yield N-hydroxyarylamines are metabolic steps that are crucial for the genotoxic properties of aromatic amines and nitroarenes, respectively. N-Hydroxyarylamines can form adducts with DNA, tissue proteins, and the blood proteins albumin and hemoglobin in a dose-dependent manner. The determination of hemoglobin adducts is a useful tool for biomonitoring exposed populations. We have established the hemoglobin binding index (HBI) [(mmole compound/mole Hb)/(mmole compound/kg body weight)] of several aromatic amines and nitroarenes in female Wistar rats. Incorporating values obtained by other researchers in the same rat strain, the logarithm of hemoglobin binding (log HBI) was plotted against several physicochemical parameters and against calculated electronic descriptors of nitroarenes and arylamines. Most arylamines and nitroarenes form hydrolyzable (e.g., sulfinamide) adducts with hemoglobin in rats. The amount of hemoglobin binding decreases with the oxidizability of the arylamines, except for compounds that are substituted with halogens in ortho or meta position. For halogen-substituted arylamines, the amount of hemoglobin binding is directly proportional to the pKa. Hemoglobin binding of nitroarenes increases with the reducibility of the nitro group. The structure activity relationships (SAR) for hemoglobin binding of nitroarenes and arylamines are comparable. The SAR found for hemoglobin binding were compared with the SAR found in the literature for mutagenicity, carcinogenicity, and cytotoxicity of arylamines and nitroarenes. In general, the mutagenicity or carcinogenicity of arylamines increases with their oxidizability. This first set of data suggests that the levels of hemoglobin binding, mutagenicity, and carcinogenicity of arylamines are not determined by the same electronic properties of the compounds, or not by these properties alone.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 34 references indexed in Scilit:
- Hemoglobin binding of monocyclic aromatic amines: Molecular dosimetry and quantitative structure activity relationships for the N-oxidationChemico-Biological Interactions, 1992
- Relative stabilities of nitrenium ions derived from heterocyclic amine food carcinogens: Relationship to mutagenicityChemico-Biological Interactions, 1992
- Relative stabilities of nitrenium ions derived from polycyclic aromatic amines. Relationship to mutagenicityChemico-Biological Interactions, 1992
- Structure-activity relationships of aromatic amines in the Ames Salmonella typhimurium assayMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Nitro group orientation, reduction potential, and direct‐acting mutagenicity of nitro‐polycyclic aromatic hydrocarbonsEnvironmental and Molecular Mutagenesis, 1991
- Biomonitoring of arylamines: hemoglobin adducts of urea and carbamate pestidesCarcinogenesis: Integrative Cancer Research, 1990
- Metabolism of Nitroaromatic CompoundsDrug Metabolism Reviews, 1987
- Relationship between polarographic reduction potential and mutagenicity of nitroarenesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1984
- MNDO molecular orbital study of nitrenium ions derived from carcinogenic aromatic amines and amidesJournal of the American Chemical Society, 1981
- The influence of methyl substitution on the mutagenicity of nitronaphthalenes and nitrobiphenylsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1981